In another update to the preliminary injunction issued August 29 in the Plavix case, the cheeky Apotex has filed an appeal with the Court of Appeals for the Federal Circuit against the preliminary injunction preventing the drug company from selling a generic version of the heart drug Plavix. The request came a day after a […]

On April 20, 2006, Amgen filed a lawsuit against Ariad in the U.S. District Court for the District of Delaware seeking a declaratory judgment that each of the claims contained in U.S. Patent No. 6,410,516, covering methods of treating human disease by regulating NF-κβ cell-signaling activity, are invalid and that Amgen has not infringed any […]

In another update to the preliminary injunction issued August 29 in the Apotex case, The Fire of Genius writes that there are two interesting things to note about Judge Stein’s decision: (1) it nowhere mentions the eBay v. MercExchange case, at all (!); and (2) Judge Stein applies the traditional pre-eBay “presumption of irreparable harm” […]

U.S. District Judge Sidney H. Stein in Manhattan issued an injunction blocking the sale of generic Plavix® (clopidogrel bisulfate) after a two-day hearing (Sanofi-Synthelabo v. Apotex Inc., 02cv2255, U.S. District Court for the Southern District of New York). Sanofi-Aventis SA and Bristol-Myers Squibb sought the preliminary injunction against Apotex Inc . to stop sales of […]

Novozymes has won a patent infringement suit against Danisco concerning infringement of a Novozymes patent on enzymes for bioethanol. Danisco has withdrawn the infringing product (Spezyme Ethyl) from the market. Spezyme Ethyl is a thermostable alpha-amylase enzyme for the liquefaction of starch at high temperatures and is used in the production of bioethanol. Amylase (1,4-a-D-Glucan […]

Last year, we detailed that the U.S. Court of Appeals for the Federal Circuit upheld a trial court decision that three patents held by Purdue Pharma LP couldn’t be enforced because of misrepresentations to the U.S. Patent and Trademark Office about the painkiller’s effectiveness thus giving Endo Pharmaceutical Holdings Inc. the right to sell a […]

In a classic tale of who said what to whom, the Court of Appeals for the Federal Circuit overturned an earlier infringement ruling of Purdue University’s patent by ACell, Inc. and denied adding a Purdue inventor to the ACell patent based in part on the inventor’s testimony to the USPTO. Cook Biotech Inc. and Purdue […]

ZymoGenetics, Inc. filed an infringement suit against Bristol-Myers Squibb over its patents related to fusion protein technology. The lawsuit, ZymoGenetics, Inc. v. Bristol-Myers Squibb Co., et al., District Court of Delaware, is for injunctive relief and damages over infringement, contributory infringement and/or inducement of infringement of US Patent Nos. 5,843,725 and 6,018,026. The ‘026 Patent […]